RETICULOCYTE COUNT OF SICKLE CELL PATIENT ATTENDING HEMATOLOGY DAY CARE UNIT, UNIVERSITY COLLEGE HOSPITAL, IBADAN, OYO STATE.

Student: Ayotomiwa Victor Ogunmiluyi
Supervisor: Mr Richard Alabi
HOD: Dr Adesola Helen Oniye
Department of Medical Laboratory Science
Basic Medical and Applied Science
Lead City University, Ibadan, Oyo State

Abstract

Sickle Cell Disease (SCD) is a hereditary blood disorder characterized by the presence of an abnormal form of hemoglobin, known as hemoglobin S (HbS). It is one of the most common genetic disorders worldwide, particularly prevalent among individuals of African, Mediterranean, Middle Eastern, and Indian descent. The aim of this study is to evaluate and analyze reticulocyte count in sickle cell patients, its objectives are; to assess the reticulocyte count in a cohort of sickle cell patients and compare them with a control group of individuals without sickle cell, to investigate reticulocyte count and clinical manifestations of sickle cell disease, and to examine the use of drugs and specific drugs used by sickle cell patients. The research adopts a cross-sectional study design to evaluate the reticulocyte count of sickle cell patients. The result of analysis revealed that the reticulocyte count and percentage of sickle cell patients is between 81-90 and 6.1-6.9 respectively. The reticulocyte count and percentage of the control group is 3.0-9.0 and 0.3-0.9 respectively. The result of analysis revealed that 50.0% of the participants are diagnosed with HbS and are on drugs, and 30.0% take folic acid, while 20.0% take astymin and vitamin C respectively. It is concluded that participants with sickle cell disease have a reticulocyte count of 81-90, and participants in the control group have a reticulocyte count of 3.0-9.0. It is recommended that patients should be educated about the significance of reticulocyte count, and the importance of monitoring and adhering to treatment plans

Full-Text Access Notice

In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication. During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.

Request authorisation from the author